SUSTAINED THERAPEUTICS
Sustained Therapeutics is a platform that allows the production of sustained-release formulations of generic drugs. Preliminary data from the lead candidate (ST-01) from a completed Phase I clinical trials for the treatment of chronic scrotal pain demonstrated sustained pain relief over a period of up to four weeks with a single injection. Sustained Therapeutics is backed by Creative Destruction Labs.
SUSTAINED THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.sustainedtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
778-388-3612
Email Addresses:
[email protected]
Total Funding:
100 K USD
Technology used in webpage:
Euro IWeb
Similar Organizations
BioHuntress Therapeutics
BioHuntress Therapeutics is a nature-inspired, scientifically validated, patent-protected drug development platform.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
PICO Portal
PICO Portal is a solution to address the growing need of fast-paced and research catalyzed.
SpheroFill
SpheroFill is a drug delivery platform that will allow for the protected, controlled release of drugs over time.
Investors List
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Sustained Therapeutics
Official Site Inspections
http://www.sustainedtherapeutics.com
- Host name: mtl200.greengeeks.net
- IP address: 198.72.126.220
- Location: Montreal Canada
- Latitude: 45.4579
- Longitude: -73.5493
- Timezone: America/Toronto
- Postal: H3E
More informations about "Sustained Therapeutics"
Sustained Therapeutics | Innovative Drug Delivery for Pain โฆ
Sustained Therapeuticsโ patented drug delivery platform is a non-opioid approach designed to relieve acute and chronic pain in a highly controlled way over longer periods with fewer side โฆSee details»
Sustained Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Sustained Therapeutics is a platform that allows the production of sustained-release formulations of generic drugs. Preliminary data from the โฆSee details»
Sustained Therapeutics - Life Sciences British Columbia
Jul 25, 2024 Website sustainedtherapeutics.com; Email [email protected] ; Address 2660 Oak Street Vancouver, BC V6H 3Z6; Leadership Contact William Annett, CEO; Dr Graeme โฆSee details»
Contact us - Sustained Therapeutics
Sustained Therapeutics is a clinical-stage biopharmaceutical company discovering, developing, and commercializing a sustained-release drug delivery platform with the potential to be an โฆSee details»
Sustained Therapeutics - LinkedIn
Sustained Therapeutics | 295 followers on LinkedIn. Delivering a novel sustained-release drug delivery platform | Sustained Therapeutics is a clinical-stage company utilizing its advanced โฆSee details»
Sustained Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Sustained Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 3 news, Disease Domain:Endocrinology and ...See details»
Sustained Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Sustained Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Sustained Therapeutics - Products, Competitors, Financials, โฆ
Headquarters Location. 2660 Oak Street Vancouver . Vancouver, British Columbia, V6H 3Z6, Canada. 778-388-3612See details»
Sustained Therapeutics, Inc. (Sustained Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
A spin-off from the University of British Columbia and the Vancouver Prostate Centre, has the potential to enable sustained release treatments for multiple other products, including in โฆSee details»
Sustained Therapeutics - BIO International Convention | BIO
Jun 6, 2023 Sustained Therapeutics is a clinical stage company developing non-opioid medicines for the treatment of pain. Our novel sustained-release delivery platform has the โฆSee details»
sustainedtherapeutics.com Reviews | scam or legit check
Sustainedtherapeutics.com has an average to good trust score. Why? It seems that sustainedtherapeutics.com is legit and safe to use and not a scam website. The review of โฆSee details»
Sustained Therapeutics Advancing Clinical Trials for Novel Drug ...
Jan 5, 2023 The World Health Organization in 2019 recognized chronic pain as a legitimate disease. Affected individuals experience impaired mobility, difficulty performing daily activities, โฆSee details»
Sustained Therapeutics Advancing Clinical Trials for Novel Drug ...
Jan 5, 2023 The World Health Organization in 2019 recognized chronic pain as a legitimate disease. Affected individuals experience impaired mobility, difficulty performing daily activities, โฆSee details»
Sustained Therapeutics Pipeline | Targeted Drug Delivery Systems
Rich pipeline based on platform technology; Sustained-release lidocaine (ST-01):Chronic Pain; Post-Operative Pain; Sustained-release gemcitabine (ST-02):Upper Tract Urothelial CarcinomaSee details»
UBC Spinoff Sustained Therapeutics Advancing Clinical Trials for โฆ
Jan 6, 2023 The World Health Organization in 2019 recognized chronic pain as a legitimate disease. Affected individuals experience impaired mobility, difficulty performing daily activities, โฆSee details»
Innovative Technology for Sustained Drug Delivery - Sustained โฆ
Discover Sustained Therapeutics' soft polymer gel, revolutionizing pain relief with controlled, long-lasting drug delivery to targeted sites.See details»
Sustained Therapeutics Announces Second Phase II Trial of
VANCOUVER, BC, March 30, 2023 /CNW/ - A Vancouver-based therapeutics company has begun a second Phase II trial of its novel long lasting non-opioid pain medication, with a โฆSee details»
Innovative Drug Delivery Solutions - Sustained Therapeutics
Sustained Therapeutics is a clinical-stage biopharmaceutical company discovering, developing, and commercializing a sustained-release drug delivery platform with the potential to be an โฆSee details»
FDAโs START and CoGenT pilot programmes: Streamlining rare โฆ
1 hour ago The programme involves collaborating with global regulatory partners, including the World Health Organization and members of the International Council for Harmonisation of โฆSee details»
News - Sustained Therapeutics
Jul 5, 2023 Sustained Therapeutics announced today regulatory clearance for a pivotal Phase II/III human trial of its second product, a novel medication for the treatment of a rare form of โฆSee details»